These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1539200)

  • 1. Cadaveric renal transplantation: multifactorial analysis of possible causes affecting graft outcome in recipients treated with and without cyclosporine.
    Isa WA; Robles JE; Rosell D; Aguera LG; de Castro F; Sanchez PL; Zudaire JJ; Errasti P; Berian JM
    Transplant Proc; 1992 Feb; 24(1):115-7. PubMed ID: 1539200
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-therapy vs triple-therapy immunosuppression in cadaveric renal transplants.
    Carmellini M; Romagnoli J; Pietrabissa A; Di Stefano R; Oleggini M; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1994 Oct; 26(5):2546-7. PubMed ID: 7940785
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of cyclosporine A on the outcome of one-haplotype identical kidney grafts from a living related donor.
    Papadimitriou M; Vakianis P; Malliara M; Economidou D; Alexopoulos E; Belechri AM; Koukoudis P; Papadopoulou D; Syrganis C; Polymenidis Z
    Transplant Proc; 1994 Oct; 26(5):2548-9. PubMed ID: 7940786
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerance induction in human kidney retransplantation: impact of repeated HLA mismatches in 156 second renal grafts.
    Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):319-21. PubMed ID: 8438317
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study.
    Masri MA; Shakuntala V; Dhawan IK; Zahir M; Shanwaz M; Hayes K; Pingle A
    Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract]   [Full Text] [Related]  

  • 8. Do steroids matter in one-haplotype pediatric renal allograft recipients on cyclosporine/azathioprine?
    David-Neto E; Ianhez LE; Nahas WC; Krasilcic S; Sabbaga E; Arap S
    Transplant Proc; 1994 Feb; 26(1):95-6. PubMed ID: 8109040
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of flow cytometry, complement-dependent cytotoxicity, and auto cross match on cadaveric renal transplant outcome.
    Christiaans M; Van den Berg-Loonen E; Ten Haaft A; Nieman F; Van Hooff J
    Transplant Proc; 1995 Feb; 27(1):1028-30. PubMed ID: 7878788
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the risk factors of late failure in renal transplantation under cyclosporine immunosuppression.
    Pallardó LM; Sánchez P; Sánchez J; García J; Beneyto I; Orero E; Rochera A
    Transplant Proc; 1994 Oct; 26(5):2536-7. PubMed ID: 7940781
    [No Abstract]   [Full Text] [Related]  

  • 11. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract]   [Full Text] [Related]  

  • 12. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydration and mannitol reduce the need for dialysis in cadaveric kidney transplant recipients treated with CyA.
    Lauzurica R; Teixidó J; Serra A; Torguet P; Bonet J; Bonal J; Borrás M; Romero R; Caralps A
    Transplant Proc; 1992 Feb; 24(1):46-7. PubMed ID: 1539337
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.
    Griñó JM; Castelao AM; Serón D; Gonzalez C; Galceran JM; Gil-Vernet S; Andrés E; Bover J; Torras J; Alsina J
    Transplant Proc; 1992 Feb; 24(1):39-41. PubMed ID: 1539329
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of cold ischemia and donor age on renal allograft outcome in the cyclosporine era.
    Cacciarelli TV; Sumrani N; DiBenedetto A; Hong JH; Sommer BG
    Transplant Proc; 1992 Oct; 24(5):2044-5. PubMed ID: 1412966
    [No Abstract]   [Full Text] [Related]  

  • 17. Causes of late graft failure in cadaveric renal transplantation.
    Bergmann LS; Roper L; Bow LM; Hull D; Bartus SA; Schweizer RT
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1340-1. PubMed ID: 8442136
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
    Banowsky LH; Wright FH; Kothmann R; Floyd M; Vick S
    Transplant Proc; 1996 Aug; 28(4):2121-4. PubMed ID: 8769175
    [No Abstract]   [Full Text] [Related]  

  • 19. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
    Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
    Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.